PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
16.39%
Positive revenue growth while OGI.TO is negative. John Neff might see a notable competitive edge here.
6.16%
Positive gross profit growth while OGI.TO is negative. John Neff would see a clear operational edge over the competitor.
-39.85%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-39.85%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
2.92%
Positive net income growth while OGI.TO is negative. John Neff might see a big relative performance advantage.
-2.20%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-2.20%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
29.60%
Share count expansion well above OGI.TO's 11.71%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
23.80%
Diluted share count expanding well above OGI.TO's 11.71%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-62.19%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
32.43%
FCF growth above 1.5x OGI.TO's 14.49%. David Dodd would verify if the firm’s strategic investments yield superior returns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-90.89%
Negative 10Y OCF/share CAGR while OGI.TO stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-90.89%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
336.85%
Positive 3Y OCF/share CAGR while OGI.TO is negative. John Neff might see a big short-term edge in operational efficiency.
228.97%
10Y net income/share CAGR of 228.97% while OGI.TO is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
228.97%
Positive 5Y CAGR while OGI.TO is negative. John Neff might view this as a strong mid-term relative advantage.
879.72%
Positive short-term CAGR while OGI.TO is negative. John Neff would see a clear advantage in near-term profit trajectory.
539.94%
Equity/share CAGR of 539.94% while OGI.TO is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
539.94%
Below 50% of OGI.TO's 1318.07%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
1391.78%
Below 50% of OGI.TO's 14413.11%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
32.51%
AR growth well above OGI.TO's 53.39%. Michael Burry fears inflated revenue or higher default risk in the near future.
2.64%
We show growth while OGI.TO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
63.87%
Similar asset growth to OGI.TO's 59.81%. Walter Schloss finds parallel expansions or investment rates.
33.53%
50-75% of OGI.TO's 47.42%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-4.80%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-65.35%
Our R&D shrinks while OGI.TO invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
26.25%
SG&A growth well above OGI.TO's 21.57%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.